EGFR and triple-negative breast carcinoma: The level of EGFR phosphorylation would significantly increase on the exposure of cells to the recombinant PKM2 protein, and the secretion of PKM2 would induce EGFR phosphorylation and activate the EGFR downstream signaling in triple-negative breast cancer cells [36].